Breakthrough in ulcerative colitis treatment? Microbiotica unveils MB310 data

Microbiotica, a clinical-stage biopharmaceutical company pioneering microbiome-based therapy, has presented significant new data on MB310, its investigational treatment for ulcerative colitis, at two prominent medical ... Read More